1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Vidutolimod (CMP-001): new trials by email Literature Review of Vidutolimod (CMP-001) trials Research Report on Vidutolimod (CMP-001)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab Vidutolimod (CMP-001), Nivolumab, [18F]F-AraG PET/CT - Melanoma | Phase 2 | Completed | Diwakar Davar | 9 | 2020-09-02 | 2026-07-02 |
Melanoma (1)
Diwakar Davar (1)
United States (1)